These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7037463)

  • 21. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
    Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
    Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteal contraception.
    Yen S; Garzo G; Liu J
    Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women.
    Lemay A; Labrie F; Ferland L; Raynaud JP
    Fertil Steril; 1979 Jan; 31(1):29-34. PubMed ID: 369890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells.
    Casper RF; Erickson GF; Rebar RW; Yen SS
    Fertil Steril; 1982 Mar; 37(3):406-9. PubMed ID: 6800851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of luteinizing hormone releasing hormone (LH-RH) in pregnant rats. I. Postnidatory effects.
    Humphrey RR; Windsor BL; Reel JR; Edgren RA
    Biol Reprod; 1977 Jun; 16(5):614-21. PubMed ID: 324526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect on corpus luteum function of luteal phase administration of a potent gonadotropin-releasing hormone analog (nafarelin).
    Schriock ED; Monroe SE; Martin MC; Henzl MR; Jaffe RB
    Fertil Steril; 1985 Jun; 43(6):844-50. PubMed ID: 3158549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot.
    Balasch J; Gómez F; Casamitjana R; Carmona F; Rivera F; Vanrell JA
    Hum Reprod; 1992 Oct; 7(9):1230-4. PubMed ID: 1479003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone antagonists: effects on the ovarian follicle and corpus luteum.
    Hall JE
    Clin Obstet Gynecol; 1993 Sep; 36(3):744-52. PubMed ID: 8403621
    [No Abstract]   [Full Text] [Related]  

  • 34. Luteolytic effect of intranasal administration of [D-Ser(TBU)6,DES-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in normal women.
    Lemay A; Labrie F; Belanger A; Raynaud JP
    Fertil Steril; 1979 Dec; 32(6):646-51. PubMed ID: 389676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey.
    Webley GE; Hodges JK; Given A; Hearn JP
    J Endocrinol; 1991 Jan; 128(1):121-9. PubMed ID: 1900320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys.
    Borghi MR; Niesvisky R; Balmaceda JP; Coy DH; Schally AV; Asch RH
    Fertil Steril; 1983 Nov; 40(5):678-82. PubMed ID: 6414849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
    Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
    Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midluteal gonadotropin-releasing hormone analog administration in early pregnancy.
    Ron-El R; Golan A; Herman A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Mar; 53(3):572-4. PubMed ID: 2137797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRFD6a has a dose-related stimulatory or inhibitory effect on the ovary in normal luteal phase women.
    Barnea ER; Maheux R; Caldwell BV; DeFazio J; DeCherney AH; Naftolin F
    J Endocrinol Invest; 1985 Aug; 8(4):297-302. PubMed ID: 3934254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.